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Abstract The existence of glucose-6-phosphate transport across
the liver microsomal membrane is still controversial. In this
paper, we show that S3483, a chlorogenic acid derivative known
to inhibit glucose-6-phosphatase in intact microsomes, caused the
intravesicular accumulation of glucose-6-phosphate when the
latter was produced by glucose-6-phosphatase from glucose and
carbamoyl-phosphate. S3483 also inhibited the conversion of
glucose-6-phosphate to 6-phosphogluconate occurring inside
microsomes in the presence of electron acceptors (NADP or
metyrapone). These data indicate that liver microsomal mem-
branes contain a reversible glucose-6-phosphate transporter,
which furnishes substrate not only to glucose-6-phosphatase, but
also to hexose-6-phosphate dehydrogenase. ß 2002 Federation
of European Biochemical Societies. Published by Elsevier Sci-
ence B.V. All rights reserved.
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1. Introduction
Glucose-6-phosphatase is a transmembrane protein [1]
present in the endoplasmic reticulum of gluconeogenic organs
(reviewed in [2,3]). It is almost speci¢c for glucose-6-phos-
phate in intact microsomes, but loses this speci¢city after
treatment of the microsomes with detergents, acting then
equally well on mannose-6-phosphate. According to the sub-
strate-transport model [4], glucose-6-phosphatase is a phos-
phatase with rather broad speci¢city, which has its catalytic
site oriented towards the lumen of the endoplasmic reticulum.
Translocases for glucose-6-phosphate, glucose and Pi would
allow the exchange of substrate and products with the cytosol.
This model is supported by several ¢ndings, including direct
evidence for the transport of glucose-6-phosphate in liver mi-
crosomes and the demonstration that this transport is defec-
tive in glycogen storage disease type Ib [5], a disease due to a
functional glucose-6-phosphatase de¢ciency [6]. Furthermore,
the gene mutated in this disease encodes a 46 kDa transmem-
brane protein that belongs to the same family as the bacterial
organophosphate transporters [7]. Finally, chlorogenic acid
and its derivatives inhibit glucose-6-phosphatase in intact
but not in detergent-treated microsomes, and do not inhibit
the pyrophosphatase activity of microsomes [8^10]. It is there-
fore thought that they act by inhibiting glucose-6-phosphate
transport. This interpretation was con¢rmed by the ¢nding
that one of these compounds, S3483, inhibits the activity of
yeast phosphoglucose isomerase when this enzyme has been
trapped inside microsomes [11].
The substrate-transport model is, however, not unani-
mously accepted. Using a ¢ltration technique, some investiga-
tors found that only a small fraction of the glucose and Pi
formed from glucose-6-phosphate appear to transit through
the lumen of liver microsomes [12] and that there is no ap-
parent transport of glucose-6-phosphate when glucose-6-phos-
phatase is inactive or if it is inhibited by vanadate [13^15].
Accordingly, a model (combined conformational-£exibility
substrate-transport model) was proposed in which the cata-
lytic site of glucose-6-phosphatase is inside the endoplasmic
reticulum membrane and is connected to the cytosol by a
channel that is permeable to glucose-6-phosphate, glucose
and Pi, and to the lumen of the organelle by a channel per-
meable to glucose and Pi, but not to glucose-6-phosphate
[15,16].
In the present paper we provide new evidence for the pres-
ence of glucose-6-phosphate transport by showing that, in
intact microsomes, the chlorogenic acid derivative S3483 in-
hibits the oxidation of glucose-6-phosphate by microsomal
hexose-6-phosphate dehydrogenase and that it also inhibits
the exit of the glucose-6-phosphate that is formed from glu-
cose and carbamoyl-phosphate.
2. Materials and methods
[14C]Glucose-6-phosphate was synthesized from [14C]glucose and
ATP with yeast hexokinase and puri¢ed by chromatography on Dow-
ex AG1-X8 (chloride form). Microsomes were prepared from over-
night-fasted male Wistar rats by ultracentrifugation and washed once
[17]. S3483 was kindly made available to us by Dr. H.J. Burger
(Aventis Pharma, Germany)
For the measurement of glucose-6-phosphate formation, the micro-
somes were incubated at 30‡C at a ¢nal concentration of 2.8 mg
protein/ml in the presence of 20 mM HEPES, pH 7.1, 100 mM
KCl, 2% polyethyleneglycol (added to allow rapid sedimentation of
the microsomes [18]), 200 mM glucose, with 50 WM S3483 or with
solvent (DMSO at a ¢nal concentration of 1%). Carbamoyl-phos-
phate was added after 5 min of preincubation. Samples of 0.4 ml
were taken at the indicated times thereafter, mixed with 4 Wl 100
mM vanadate and centrifuged at 10 000Ug for 15 s. The supernatant
and pellet were immediately separated and mixed with 0.2 ml 10%
HClO4, the whole arrest procedure taking about 30 s. The perchloric
acid extracts were neutralized with K2CO3 and centrifuged; the super-
natants were diluted three-fold with water and applied on Dowex
AG1-X8 columns (1 ml bed volume, in Pasteur capillary pipettes) to
separate glucose from glucose-6-phosphate. The columns were washed
with 2 ml H2O; glucose-6-phosphate was eluted with 1.7 ml 0.5 M
NaCl and was assayed spectrophotometrically [19] using Leuconostoc
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mesenteroides glucose-6-phosphate dehydrogenase in an Aminco
Chance spectrophotometer.
For the measurement of the uptake of radioactive glucose-6-phos-
phate, microsomes (¢nal concentration 7 mg/ml) were incubated with
20 mM HEPES, pH 7.1, 100 000 cpm [14C]glucose-6-phosphate, 10 or
50 WM glucose-6-phosphate, 1 mM MgCl2, 1 mM vanadate (to block
glucose-6-phosphatase activity [20]) and with the indicated concentra-
tions of electron acceptor in a ¢nal volume of 50 Wl. At the indicated
times, the sample was mixed with 1 ml of an ice-cold bu¡er containing
10 mM HEPES, pH 7.1, 100 mM KCl and 0.25 M sucrose, and
rapidly ¢ltered onto a Supor0-200 ¢lter (25 mm diameter; 0.2 Wm
pores), which was washed with 10 ml of the HEPES/KCl/sucrose
bu¡er and counted for radioactivity in the presence of 5 ml Hisafe
II scintillation cocktail (Packard). The whole arrest procedure took
about 30 s.
To identify the radioactive compound accumulating in microsomes,
the experiment was terminated by ¢ltration, as above, and the ¢lter
was immediately transferred into 1 ml 10% HClO4, with which it was
vigorously shaken. The perchloric acid extract was neutralized and
500 Wl of it was incubated in a medium containing 20 mM HEPES,
pH 7.1, 1 mM MgCl2, 1 mM NADP with or without 0.5 U/ml 6-phos-
phogluconate dehydrogenase (from Torula yeast, type V, from Sigma)
in a ¢nal volume of 1 ml. After 30 min at 30‡C, the samples were
loaded onto AG1-X8 columns (Cl3 form, 1 ml bed volume, in a
Pasteur capillary pipette), which were washed successively with 5 ml
water, 5 ml 150 mM NaCl and 5 ml 300 mM NaCl.
3. Results and discussion
3.1. Inhibition of the e¥ux of glucose-6-phosphate by S3483
Glucose-6-phosphatase is able to catalyze the synthesis of
glucose-6-phosphate from glucose and carbamoyl-phosphate
[21]. According to the substrate-transport model, this synthe-
sis should involve the entry of glucose and carbamoyl-phos-
phate in the microsomes, the synthesis of glucose-6-phosphate
in the luminal compartment and its exit from the microsomes
through the glucose-6-phosphate transporter. If such is the
case, S3483 should cause the intramicrosomal accumulation
of glucose-6-phosphate.
In the experiment shown in Fig. 1, microsomes were incu-
bated in the presence of glucose and carbamoyl-phosphate
with or without S3483. At the indicated incubation times,
the microsomes were rapidly centrifuged and perchloric acid
extracts were prepared from the pellets and the supernatants.
The ¢gure shows that S3483 inhibited the appearance of glu-
cose-6-phosphate in the medium but that it caused a marked
increase in the intravesicular concentration of this phosphate
ester which reached W1 mM. The e¡ect of S3483 to cause the
appearance of a gradient between the intravesicular and the
extravesicular concentrations of glucose-6-phosphate indicates
that it inhibits glucose-6-phosphate transport out of the mi-
crosomes. Due to this inhibition, the intramicrosomal concen-
tration of glucose-6-phosphate increases until the rate of hy-
drolysis matches the rate of synthesis, explaining the
appearance of a steady state and the fact that S3483 decreases
the total formation of glucose-6-phosphate.
That the inhibition exerted by S3483 is not complete is due
to the fact that part of the microsomes are not latent (W5^
10%) and that disrupted microsomes catalyze much more rap-
idly the synthesis of glucose-6-phosphate from carbamoyl-
phosphate and glucose than intact microsomes [21], owing
probably to the rate-limiting aspect of carbamoyl-phosphate
transport.
On a theoretical basis, the following possibilities can be
envisaged to account for the inhibitory e¡ect of S3483 and
other chlorogenic acid derivatives in the context of the com-
bined conformational-£exibility substrate-transport model:
that they interact directly with glucose-6-phosphatase (i), or
that they block the hypothetical internal (ii) or external (iii)
channel. Explanations (i) and (ii) are not compatible with the
observation of intramicrosomal accumulation of glucose-6-
phosphate. Blocking of the external channel could cause the
accumulation of a few molecules of glucose-6-phosphate, but
not as much as observed here. Assuming that glucose-6-phos-
phatase represents 0.1% of microsomal protein and has a
molecular mass of 35 000 Da [23], the microsomal accumula-
tion of glucose-6-phosphate that we observe corresponds to
W100 molecules per molecule of glucose-6-phosphatase.
3.2. Inhibition of hexose-6-phosphate dehydrogenase by S3483
If S3483 inhibits glucose-6-phosphate transport across the
endoplasmic reticulum membrane, it should slow down the
oxidation of glucose-6-phosphate by hexose-6-phosphate de-
hydrogenase, an enzyme present in the lumen of the endoplas-
mic reticulum [24]. The system used to test this e¡ect is based
on the observation that metyrapone is a substrate for a re-
ductase present in the endoplasmic reticulum [25]. This agent
is therefore expected to stimulate the conversion of glucose-6-
phosphate to 6-phosphogluconate in intact microsomes by
allowing re-conversion of microsomal NAD(P)H to
NAD(P).
As shown in Fig. 2, metyrapone caused a dose-dependent
increase in the accumulation of radioactivity in microsomes
incubated with [14C]glucose-6-phosphate together with 1 mM
vanadate, which completely inhibits glucose-6-phosphatase ac-
tivity. The accumulated radioactivity elutes from an anion-
exchanger column at higher concentrations of NaCl than glu-
cose-6-phosphate (Fig. 3), suggesting that the formed com-
pound corresponds to 6-phosphogluconate. This conclusion
was con¢rmed by the observation that incubation of the neu-
tralized perchlorate extract with 6-phosphogluconate dehydro-
genase displaced the peak of radioactivity. Since hexose-6-
phosphate dehydrogenase is not a transmembrane protein,
but is present in the lumen of microsomes [24,26], the forma-
tion of 6-phosphogluconate inside microsomes indicates that
Fig. 1. E¡ect of S3483 on the formation of glucose-6-phosphate by
intact microsomes. Liver microsomes were preincubated for 5 min
with 200 mM glucose with or without 50 WM S3483 before the ad-
dition of 10 mM carbamoyl-phosphate. At the indicated times the
samples were rapidly mixed with vanadate and centrifuged;
perchloric extracts were prepared from the supernatants and pellets.
The concentration in the microsomal lumen was calculated by as-
suming a luminal water content of 3.2 Wl/mg protein [22].
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glucose-6-phosphate has access to the lumen of microsomes,
in support of the substrate-transport model.
NADP was also found to stimulate the accumulation of
radioactivity in intact microsomes, but to a lesser extent
than metyrapone (Fig. 2). The accumulated product also cor-
responded to 6-phosphogluconate (not shown). These results
suggest that NADP can slowly penetrate into liver micro-
somes, in agreement with the observation that hexose-6-phos-
phate dehydrogenase activity is not completely latent at 37‡C
[26].
Fig. 4 shows that S3483 inhibited the accumulation of ra-
dioactive 6-phosphogluconate in microsomes incubated with
metyrapone or NADP, but that it had no e¡ect in the absence
of electron acceptor. It had no e¡ect on the accumulated
radioactivity, when added just before ¢ltration, indicating
that it did not decrease the retention of microsomes on the
¢lters. Other experiments showed that 50 WM S3483 had no
e¡ect on hexose-6-phosphate dehydrogenase activity (mea-
sured spectrophotometrically with 0.1 mM glucose-6-phos-
phate and 0.5 mM NADP) in detergent-treated microsomes
(not shown).
These experiments and previous work show therefore that
three di¡erent enzymes that use glucose-6-phosphate (glucose-
6-phosphatase [8^10], hexose-6-phosphate dehydrogenase (this
paper) and yeast phosphoglucose isomerase, when this enzyme
has been arti¢cially entrapped into liver microsomes [11]) are
inhibited by S3483 when they are present in intact micro-
somes, but not when they are free, or when the microsomes
have been treated with detergents. The conclusion is therefore
that S3483 acts on a common step for the utilization of glu-
cose-6-phosphate by these enzymes, i.e. the transport of this
phosphate ester across the microsomal membrane. This trans-
port, which is de¢cient in glycogen storage disease type Ib, is
carried out by the putative transporter that is mutated in this
disorder [7], as con¢rmed by in vitro experiments in which
wild-type and mutated proteins have been expressed in COS
cells [27]. Furthermore, the protein that binds chlorogenic
acid derivatives is apparently absent from the liver of at least
one patient with glycogen storage disease type Ib [28].
Our experiments support nonetheless the conclusion of Xie
et al. [16] that glucose-6-phosphate is not exchanged with Pi
when it crosses the microsomal membrane: Pi crosses the
membrane in the same direction as glucose-6-phosphate in
the experiments with carbamoyl-phosphate, whereas no Pi is
formed in the second type of experiments due to inhibition of
glucose-6-phosphatase by vanadate. These data, as well as the
¢nding that glucose-6-phosphatase is still active when Pi e¥ux
from microsomes is blocked through the formation of a com-
plex with Pb2 [11], indicate that the mammalian glucose-6-
phosphate transporter behaves as a uniport, contrasting with
its bacterial homolog uhpT, which behaves as a hexose-6-
phosphate/Pi antiport [29]. This dissimilarity is not surprising,
considering the low degree of identity between these proteins
(W20%) and the fact that they belong to a superfamily com-
prising uniporters, symporters and antiporters [30].
4. Conclusion
This work adds two new pieces of evidence for the presence
of a glucose-6-phosphate transporter in liver microsomes. The
fact that S3483 and other chlorogenic acid derivatives inhibit
glucose-6-phosphate hydrolysis in intact microsomes, in hepa-
tocytes [8^10] and in vivo [31,32] indicates that glucose-6-
phosphate transport is a mandatory step for its hydrolysis
by glucose-6-phosphatase. The apparent absence of glucose-
6-phosphate uptake reported by Xie et al. [16] is probably due
to the fact that the ¢ltration technique used by these authors
is not rapid enough to prevent the exit of glucose-6-phosphate
during the washings, particularly when no transport inhibitor
is included in the washing solution. By contrast, glucose-6-
phosphate transport could be demonstrated, even in the pres-
ence of vanadate, in an experimental setting in which DIDS,
an inhibitor of glucose-6-phosphate translocase [33], was in-
cluded in the washing bu¡er [34]. By the same token, the
apparent release of glucose and Pi from the catalytic site of
glucose-6-phosphatase directly into the medium is due to the
fact that the membrane of most microsomal vesicles is readily
permeable to glucose and Pi [35,36]. This is supported by the
observation that about 80% of the Pi that is formed from
Fig. 2. E¡ect of metyrapone and NADP on the accumulation of ra-
dioactivity in microsomes incubated with [14C]glucose-6-phosphate.
Microsomes were incubated with [14C]glucose-6-phosphate, 50 WM
glucose-6-phosphate, 1 mM vanadate and with the indicated concen-
trations of electron acceptor. Samples were ¢ltered at the indicated
times (2 and 5 min).
Fig. 3. Identi¢cation of the accumulated radioactive product as
6-phosphogluconate. Microsomes were incubated for 10 min with
100 000 cpm [14C]glucose-6-phosphate, 50 WM glucose-6-phosphate,
1 mM vanadate and 1 mM metyrapone before being ¢ltered. The
radioactive material retained on the ¢lter was eluted and treated or
not with 6-phosphogluconate dehydrogenase and NADP before
being chromatographed on AG1-X8.
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glucose-6-phosphate is found inside microsomes when incuba-
tions are run in the presence of Pb2, which traps Pi as a lead
phosphate precipitate [11].
Acknowledgements: This work was supported by the Concerted re-
search action program of the Communaute¤ Franc°aise de Belgique;
the Belgian Federal Service for Scienti¢c, Technical and Cultural af-
fairs; and by the Juvenile Diabetes Foundation International. The
authors thank G. Noe«l for her help in the experimental work and
H.G. Hers and M. Veiga-da-Cunha for their comments.
References
[1] Pan, C.J., Lei, K.J., Annabi, B., Hemrika, W. and Chou, J.Y.
(1998) J. Biol. Chem. 273, 6144^6148.
[2] van de Werve, G., Lange, A., Newgard, C., Me¤chin, M.C., Li, Y.
and Berteloot, A. (2000) Eur. J. Biochem. 267, 1533^1549.
[3] Van Schaftingen, E. and Gerin, I. (2002) Biochem. J. 362, 513^
532.
[4] Arion, W.J., Wallin, B.K., Lange, A.J. and Ballas, L.M. (1975)
Mol. Cell. Biochem. 6, 75^83.
[5] Igarashi, Y., Kato, S., Narisawa, K., Tada, K., Amano, Y.,
Mori, T. and Takeuchi, S. (1984) Biochem. Biophys. Res. Com-
mun. 119, 593^597.
[6] Narisawa, K., Igarashi, Y., Otomo, H. and Tada, K. (1978)
Biochem. Biophys. Res. Commun. 83, 1360^1364.
[7] Gerin, I., Veiga-da-Cunha, M., Achouri, Y., Collet, J.-F. and
Van Schaftingen, E. (1997) FEBS Lett. 419, 235^238.
[8] Arion, W.J., Can¢eld, W.K., Ramos, F.C., Schindler, P.W., Bur-
ger, H.J., Hemmerle, H., Schubert, G., Below, P. and Herling,
A.W. (1997) Arch. Biochem. Biophys. 339, 315^322.
[9] Arion, W.J., Can¢eld, W.K., Ramos, F.C., Su, M.L., Burger,
H.J., Hemmerle, H., Schubert, G., Below, P. and Herling,
A.W. (1998) Arch. Biochem. Biophys. 351, 279^285.
[10] Hemmerle, H., Burger, H.J., Below, P., Schubert, G., Rippel, R.,
Schindler, P.W., Paulus, E. and Herling, A.W. (1997) J. Med.
Chem. 40, 137^145.
[11] Gerin, I., Noe«l, G. and Van Schaftingen, E. (2001) Diabetes 50,
1531^1538.
[12] Xie, W., van de Werve, G. and Berteloot, A. (2001) J. Membr.
Biol. 179, 113^126.
[13] St-Denis, J.F., Berteloot, A., Vidal, H., Annabi, B. and van de
Werve, G. (1995) J. Biol. Chem. 270, 21092^21097.
[14] Lei, K.J., Chen, H., Pan, C.J., Ward, J.M., Mosinger, B., Lee,
E.J., Westphal, H., Mans¢eld, B.C. and Chou, J.Y. (1996) Nat.
Genet. 13, 203^209.
[15] Xie, W., van de Werve, G. and Berteloot, A. (2001) FEBS Lett.
504, 23^26.
[16] Schulze, H.U., Nolte, B. and Kannler, R. (1986) J. Biol. Chem.
261, 16571^16578.
[17] Niculescu, L. and Van Schaftingen, E. (1998) Diabetologia 41,
947^954.
[18] Banhegyi, G., Braun, L., Marcolongo, P., Csala, M., Fulceri, R.,
Mandl, J. and Benedetti, A. (1996) Biochem. J. 315, 171^176.
[19] Michal, G., 1988. In: Bergmeyer, H.U (Ed.), Methods of Enzy-
matic Analysis, 3d edn. Revised, Vol. 6, 191^198, VCH-Verlags-
geselchaft, Weinheim.
[20] Singh, J., Nordlie, R.C. and Jorgenson, R.A. (1981) Biochim.
Biophys. Acta 678, 477^482.
[21] Lueck, J.D. and Nordlie, R.C. (1970) Biochem. Biophys. Res.
Commun. 39, 190^196.
[22] Marcolongo, P., Fulceri, R., Giunti, R., Burchell, A. and Bene-
detti, A. (1996) Biochem. Biophys. Res. Commun. 219, 916^922.
[23] Speth, M. and Schulze, H.U. (1992) Eur. J. Biochem. 208, 643^
650.
[24] Hori, S.H. and Takahashi, T. (1977) Biochim. Biophys. Acta 496,
1^11.
[25] Maser, E. and Netter, K.J. (1989) Biochem. Pharmacol. 38,
3049^3054.
[26] Takahashi, T. and Hori, S.H. (1978) Biochim. Biophys. Acta 524,
262^276.
[27] Chen, L.Y., Lin, B., Pan, C.J., Hiraiwa, H. and Chou, J.Y.
(2000) J. Biol. Chem. 275, 34280^34286.
[28] Kramer, W., Burger, H.J., Arion, W.J., Corsiero, D., Girbig, F.,
Weyland, C., Hemmerle, H., Petry, S., Habermann, P. and Her-
ling, A. (1999) Biochem. J. 339, 629^638.
[29] Maloney, P.C., Ambudkar, S.V., Anatharam, V., Sonna, L.A.
and Varadhachary, A. (1990) Microbiol. Rev. 54, 1^17.
[30] Marger, M.D. and Saier, M.H. (1993) Trends Biochem. Sci. 18,
13^20.
[31] Herling, A.W., Burger, H.J., Schwab, D., Hemmerle, H., Below,
P. and Schubert, G. (1998) Am. J. Physiol. 274, G1087^G1093.
[32] Herling, A.W., Burger, H.J., Schubert, G., Hemmerle, H., Schae-
fer, H. and Kramer, W. (1999) Eur. J. Pharmacol. 386, 75^82.
[33] Zoccoli, M.A. and Karnovsky, M.L. (1980) J. Biol. Chem. 255,
1113^1119.
[34] Banhegyi, G., Marcolongo, P., Fulceri, R., Hinds, C., Burchell,
A. and Benedetti, A. (1997) J. Biol. Chem. 272, 13584^13590.
[35] Marcolongo, P., Banhegyi, G., Benedetti, A., Hinds, C.J. and
Burchell, A. (1998) J. Clin. Endocrinol. Metab. 83, 224^229.
[36] Meissner, G. and Allen, R. (1981) J. Biol. Chem. 256, 6413^6422.
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